of the 84 patients evaluable for efficacy , clinical cure was achieved in 91 % , 85 % , and 89 % of ceftizoxime- ( 20/22 ) , cefotaxime- ( 23/27 ) , and latamoxef-treated ( 31/35 ) patients , respectively .
C0007560
ceftizoxime
C0007554
cefotaxime